Pazopanib: a promising new agent in the treatment of soft tissue sarcomas

ISSN： 1479-6694

Source： Future Oncology, Vol.7, Iss.12, 2011-12, pp. : 1373-1383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New drugs for the treatment of metastatic or refractory soft tissue sarcomas in children

By Gupta Abha A Pappo Alberto S

Future Oncology, Vol. 2, Iss. 5, 2006-10 ,pp. : 675-685

Future Medicine

Access to resources Recommend Favorite

Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas

The Oncologist, Vol. 23, Iss. 1, 2018-01 ,pp. : 71-83

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Importance of a Multidisciplinary Group in the Treatment of Soft Tissue Sarcomas

By Wiklund T. Huuhtanen R. Blomqvist C. Tukiainen E. Virolainen M. Virkkunen P. Asko-Seljavaara S. Bjorkenheim J.M. Elomaa I.

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 269-273

Elsevier

Access to resources Recommend Favorite

Pazopanib for the Treatment of Soft Tissue Sarcoma – Where Does It Fit?

By Mallick Atrayee Basu Narasimhan Vivek Soman Neelesh Chawla Sant P

The Journal of OncoPathology, Vol. 2, Iss. 2, 2014-06 ,pp. : 59-63

Optimal Clinical Ltd

Access to resources Recommend Favorite

Soft Tissue Sarcomas

By Womer R.B.

European Journal of Cancer, Vol. 33, Iss. 13, 1997-11 ,pp. : 2230-2234

Elsevier

Access to resources Recommend Favorite